Table 3 Data on adverse outcomes and adverse events by intervention group in the followed hospitalised patients

Hospital LOS (days) [mean ± SD]

35.3 ± 2.7

41.8 ± 3.5

< 0.01

-

-

Patients intubated [n (%)]

4 (15.3)

12 (42.8)

0.03

0.36 (0.27–0.97)

3.64

Hospital mortality [n (%)]

2 (6.4)

10 (29.4)

0.04

0.23 (0.2–0.94)

8.60

Muscle weakness [n (%)]

2 (7.7)

6 (21.4)

0.02

0.36 (0.19–0.98)

7.28

Adverse events^a [n (%)]

21 (1.6)

22 (1.6)

0.84

1.11 (0.39–3.22)

-

Cephalalgia

6 (0.5)

7 (0.5)

-

-

-

Dyspnoea

6 (0.5)

6 (0.4)

-

-

-

Pain

5 (0.3)

4 (0.3)

-

-

-

Hypertension

4 (0.2)

3 (0.2)

-

-

-

Dizziness

1 (0.1)

2 (0.2)

-

-

-